Cannabinoid receptors as novel targets for the treatment of melanoma

FASEB Journal

Volumn 20, Issue 14, 2006, Pages

  Blázquez, Cristina ^a   Carracedo, Arkaitz ^a   Barrado, Lucía ^b   Real, Pedro José ^c   Fernández Luna, José Luis ^c   Velasco, Guillermo ^a   Malumbres, Marcos ^b   Guzmán, Manuel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Centro Nacional de Investigations Oncológicas   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antitumoral drug; Cell proliferation; Experimental therapeutics; G protein coupled receptor

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; PROTEIN KINASE B; ANTINEOPLASTIC AGENT; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; ANIMAL; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CANNABINOIDS; CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; MELANOCYTES; MELANOMA; MICE; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 33845627660     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6638fje     Document Type: Article

References (47)

1. Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer. Inst. 97, 1407-1427
2. Thompson, J. F., Scolyer, R. A., and Kefford, R. F. (2005) Cutaneous melanoma. Lancet 365, 687-701
3. National Cancer Institute, SEER Cancer Statistics Review 1975-2002: http://seer.cancer.gov/csr/1975_2002/results_merged/sect_16_melanoma.pdf (accessed June 1, 2006)
4. Tsao, H., Atkins, M. B., and Sober, A. J. (2004) Management of cutaneous melanoma. N. Engl. J. Med. 351, 998-1012
5. Chudnovsky, Y., Khavari, P. A., and Adams, A. E. (2005) Melanoma genetics and the development of rational therapeutics. J. Clin. Invest. 115, 813-824
6. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949
7. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90
8. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R., et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202
9. Piomelli, D. (2003) The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4, 873-884
10. Tramer, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J., Moore, R. A., and McQuay, H. J. (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br. Med. J. 323, 16-21
11. Guzmán, M. (2003) Cannabinoids: potential anticancer agents. Nat. Rev. Cancer. 3, 745-755
12. Hall, W., Christie, M., and Currow, D. (2005) Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol. 6, 35-42
13. Munson, A. E., Harris, L. S., Friedman, M. A., Dewey, W. L., and Carchman, R. A. (1975) Antineoplastic activity of cannabinoids. J. Natl. Cancer Inst. 55, 597-602
14. Galve-Roperh, I., Sánchez, C., Cortés, M. L., Gómez del Pulgar, T., Izquierdo, M., and Guzmán, M. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6, 313-319
15. Bifulco, M., and Di Marzo, V. (2002) Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat. Med. 8, 547-550
16. 9- tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fund. Appl. Toxicol. 30, 109-117
17. Grotenhermen, F. (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42, 327-360
18. Iversen, L. (2005) Long-term effects of exposure to cannabis. Curr. Op. Pharmacol. 5, 69-72
19. 9- tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br. J. Cancer. 95, 197-203
20. Casanova, M. L., Blázquez, C., Martínez-Palacio, J., Villanueva, C., Fernández-Aceñero, M. J., Huffman, J. W., Jorcano, J. L., and Guzmán, M. (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Invest. 111, 43-50
21. Blázquez, C., Casanova, M. L., Planas, A., Gómez del Pulgar, T., Villanueva, C., Fernández-Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., and Guzmán, M. (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529-531
22. Blázquez, C., González-Feria, L., Álvarez, L., Haro, A., Casanova, M. L., and Guzmán, M. (2004) Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res. 64, 5617-5623
23. Gutiérrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y., Prosper, F., Núñez, G., and Fernández-Luna, J. L. (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κ B activation. J. Biol. Chem. 277, 41701-41705
24. Kitamura, T., Ogawa, W., Sakaue, H., Hino, Y., Kuroda, S., Takata, M., Matsumoto, M., Maeda, T., Konishi, H., Kikkawa, U., and Kasuga, M. (1998) Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18, 3708-3717
25. Gómez del Pulgar, T., de Ceballos, M. L., Guzmán, M., and Velasco, G. (2002) Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 277, 36527-3633
26. Malumbres, M., and Barbacid, M. (2001) To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer. 1, 222-231
27. 1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem. J. 347, 369-373
28. Bouaboula, M., Poinot-Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., and Casellas, P. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312, 637-641
29. Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyanis, A., and Kunos, G. (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem. J. 346, 835-840
30. 1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol. Pharmacol. 58, 814-820
31. McAllister, S., Chan, C., Taft, R., Luu, T., Abood, M., Moore, D., Aldape, K., Yount, G. (2005) Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. J. NeuroOncol. 74, 31-40
32. Bifulco, M., Laezza, C., Portella, G., Vitale, M., Orlando, P., De Petrocellis, L., and Di Marzo, V. (2001) Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J. 15, 2745-2747
33. Molina-Holgado, E., Vela, J. M., Arevalo-Martín, A., Almazán, G., Molina-Holgado, F., Borrell, J., and Guaza, C. (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol 3-kinase/Akt signaling. J. Neurosci. 22, 9742-9753
34. Samson, M. T., Small-Howard, A., Shimoda, L. M., Koblan-Huberson, M., Stokes, A. J., and Turner, H. (2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J. Immunol. 170, 4953-4962
35. Gómez del Pulgar, T., Velasco, G., Sánchez, C., Haro, A., and Guzmán, M. (2002) De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem. J. 363, 183-188
36. Bellacosa, A., Kumar, C. C., Di Cristofano, A., and Testa, J. R. (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94, 29-86
37. Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., and Khavari, P. A. (2005) Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat. Genet. 37, 745-749
38. Wu, H., Goel, V., and Haluska, F. G. (2003) PTEN signaling pathways in melanoma. Oncogene. 22, 3113-3122
39. Stahl, J. M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J. Q., Bosenberg, M. W., Kester, M., Sandirasegarane, L., and Robertson, G. P. (2004) Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64, 7002-7010
40. Chin, L. (2003) The genetics of malignant melanoma: lessons from mouse and man. Nat. Rev. Cancer. 3, 559-570
41. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol. Pharmacol. 54, 834-843
42. Bouaboula, M., Poinot Chazel, C., Marchand, J., Canat, X., Bourrie, B., Rinaldi-Carmona, M., Calandra, B., Le Fur, G., and Casellas, P. (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237, 704-711
43. Sánchez, C., de Ceballos, M. L., Gómez del Pulgar, T., Rueda, D., Corbacho, C., Velasco, G., Galve-Roperh, I., Huffman, J.W., Ramón y Cajal, S., and Guzmán, M. (2001) Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor. Cancer Res. 61, 5784-5789
44. Segal, N. H., Pavlidis, P., Noble, W. S., Antonescu, C. R., Viale, A., Wesley, U. V., Busam, K., Gallardo, H., DeSantis, D., Brennan, M. et al. (2003) Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J. Clin. Oncol. 21, 1775-1781
45. Calignano, A., La Rana, G., Giuffrida, A., and Piomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature 394, 277-281
46. 2 receptors. Science 310, 329-332
47. Klein, T. W. (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5, 400-411